SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

PARNAX LAB

BSE: 506128 29 Jun 2025
Healthcare
₹ 100
Parnax Lab Limited specializes in Pharmaceuticals within the Healthcare sector.

PARNAX LAB - Share Price & Details

Market Cap
₹119.0
High /Low
194.0 / 81.0
Stock P/E
10.3
Book Value
₹72.4
Dividend Yield
0.0
ROCE
13.8
ROE
₹14.9
Face Value
10.0
PEG Ratio
0.24
EVEBITDA
₹6.53
Debt
69.5
CMP / FCF
31.7
Debt to equity
₹0.84
NP Ann
11.5
High price all time
194.0
Piotroski score
₹7.0
Graham Number
128.0
No. Eq. Shares
1.15
Net CF
₹0.09
Net profit
11.5
Price to book value
1.43
Interest Coverage
₹3.91
Low price all time
8.4
Industry PE
32.7
Reserves
₹71.6
Free Cash Flow
₹16.4

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
PARNAX LAB LTD.NANANANA119.010.3
CHOKSI LABORATORIES LTD.NANANANA11475.2
SAMRAT PHARMACHEM LTD.NANANANA11215.7

Peer Comparison Chart


About PARNAX LAB

Parnax Lab Limited, with Security Code 506128, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Parnax Lab Ltd Shows Resilience with 511.50% Growth Amid Recent Price Fluctuations

(21 Jun 2025)
Parnax Lab Ltd, a microcap in the Pharmaceuticals & Biotechnology sector, is experiencing notable buying activity despite a recent stock...
Read more →

Parnax Lab Faces Intense Selling Pressure Amid Consecutive Losses and Declining Stock Performance

(14 Jun 2025)
Parnax Lab Ltd is experiencing notable selling pressure, with the stock declining over the past three days. Despite recent gains over the...
Read more →

Parnax Lab Faces Intense Selling Pressure Amid Consecutive Losses and Market Challenges

(12 Jun 2025)
Parnax Lab Ltd is experiencing notable selling pressure, with its stock declining over the past two days. Despite a strong monthly...
Read more →

Who are in the management team of Parnax Lab?

(07 Jun 2025)
As of March 2022, the management team of Parnax Lab includes Prakash M Shah (CEO), Baiju M Shah (CFO), and several directors, including Vindyak B Desai,...
Read more →

Parnax Lab Faces Increased Selling Pressure Amid Significant Year-to-Date Losses

(05 Jun 2025)
Parnax Lab Ltd is experiencing notable selling pressure, with the stock down for two consecutive days. Despite a strong monthly performance,...
Read more →

Parnax Lab Faces Increased Selling Pressure Amid Notable Price Decline and Market Shift

(04 Jun 2025)
Parnax Lab Ltd is experiencing notable selling pressure, marking a shift after five days of gains. Despite a recent weekly outperformance,...
Read more →